
|Articles|January 15, 2021
Supplements and Featured Publications
- The Impact and Unmet Needs Associated With Dementia- Related Psychosis
The Impact and Unmet Needs Associated with Dementia-Related Psychosis
Advertisement
This publication is sponsored by Acadia Pharmaceuticals, Inc.
This Clinical Brief explores the prevalence and burden associated with dementia-related psychosis, underscoring a critical unmet need for effective therapy.
.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
How Effective and Safe Are GLP-1s for Weight Loss?
4
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
5















































